[Economic aspects. Cost-effectiveness, cost-benefit analysis].

P Durieux
Author Information

Abstract

No abstract text available.

MeSH Term

Bronchodilator Agents
Cost of Illness
Cost-Benefit Analysis
Delivery of Health Care
Europe
Follow-Up Studies
Health Care Costs
Health Resources
Humans
Insurance, Health
Lung Diseases, Obstructive
Politics
Public Health
Quality of Life
Reproducibility of Results
Respiratory Therapy

Chemicals

Bronchodilator Agents